Connection

Mark George to Treatment Outcome

Back to Details
This is a "connection" page, showing publications Mark George has written about Treatment Outcome.
Mark George
Connection Strength
2.092
Treatment Outcome
  1. Pursuing personalized medicine for depression by targeting the lateral or medial prefrontal cortex with Deep TMS. JCI Insight. 2023 02 22; 8(4).
    View in: PubMed
    Score: 0.093
  2. TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic. Brain Stimul. 2021 Nov-Dec; 14(6):1508-1510.
    View in: PubMed
    Score: 0.085
  3. Treatment of Adults with Autism and Major Depressive Disorder Using Transcranial Magnetic Stimulation: An Open Label Pilot Study. Autism Res. 2020 03; 13(3):346-351.
    View in: PubMed
    Score: 0.075
  4. Exposure Therapy and Simultaneous Repetitive Transcranial Magnetic Stimulation: A Controlled Pilot Trial for the Treatment of Posttraumatic Stress Disorder. J ECT. 2019 Mar; 35(1):53-60.
    View in: PubMed
    Score: 0.071
  5. Prefrontal versus motor cortex transcranial direct current stimulation (tDCS) effects on post-surgical opioid use. Brain Stimul. 2017 Nov - Dec; 10(6):1096-1101.
    View in: PubMed
    Score: 0.064
  6. Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers. Drug Alcohol Depend. 2017 05 01; 174:98-105.
    View in: PubMed
    Score: 0.062
  7. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study. Brain Stimul. 2016 Mar-Apr; 9(2):251-7.
    View in: PubMed
    Score: 0.056
  8. The Efficacy of Daily Prefrontal Repetitive Transcranial Magnetic Stimulation (rTMS) for Burning Mouth Syndrome (BMS): A Randomized Controlled Single-blind Study. Brain Stimul. 2016 Mar-Apr; 9(2):234-42.
    View in: PubMed
    Score: 0.056
  9. Daily left prefrontal repetitive transcranial magnetic stimulation for medication-resistant burning mouth syndrome. Int J Oral Maxillofac Surg. 2015 Aug; 44(8):1048-51.
    View in: PubMed
    Score: 0.055
  10. Efficacy and Safety of Low-field Synchronized Transcranial Magnetic Stimulation (sTMS) for Treatment of Major Depression. Brain Stimul. 2015 Jul-Aug; 8(4):787-94.
    View in: PubMed
    Score: 0.054
  11. A pilot study to investigate the induction and manipulation of learned helplessness in healthy adults. Psychiatry Res. 2014 Nov 30; 219(3):631-7.
    View in: PubMed
    Score: 0.051
  12. A two-site pilot randomized 3 day trial of high dose left prefrontal repetitive transcranial magnetic stimulation (rTMS) for suicidal inpatients. Brain Stimul. 2014 May-Jun; 7(3):421-31.
    View in: PubMed
    Score: 0.050
  13. Transcranial direct current stimulation (tDCS) reduces postsurgical opioid consumption in total knee arthroplasty (TKA). Clin J Pain. 2013 Nov; 29(11):925-8.
    View in: PubMed
    Score: 0.049
  14. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depress Anxiety. 2011 Nov; 28(11):973-80.
    View in: PubMed
    Score: 0.042
  15. Safety, tolerability, and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. J ECT. 2011 Mar; 27(1):18-25.
    View in: PubMed
    Score: 0.041
  16. Transcranial magnetic stimulation for the treatment of depression. Expert Rev Neurother. 2010 Nov; 10(11):1761-72.
    View in: PubMed
    Score: 0.040
  17. Time course of therapeutic response, and durability, of the different brain stimulation methods--from the Editor-in Chief's desk. Brain Stimul. 2010 Oct; 3(4):185-6.
    View in: PubMed
    Score: 0.040
  18. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Arch Gen Psychiatry. 2010 May; 67(5):507-16.
    View in: PubMed
    Score: 0.038
  19. Feasibility of simultaneous cognitive behavioral therapy and left prefrontal rTMS for treatment resistant depression. Brain Stimul. 2010 Oct; 3(4):207-10.
    View in: PubMed
    Score: 0.038
  20. Neural network dysfunction in bipolar depression: clues from the efficacy of lamotrigine. Biochem Soc Trans. 2009 Oct; 37(Pt 5):1080-4.
    View in: PubMed
    Score: 0.037
  21. The effect of daily prefrontal repetitive transcranial magnetic stimulation over several weeks on resting motor threshold. Brain Stimul. 2009 Jul; 2(3):163-7.
    View in: PubMed
    Score: 0.036
  22. Repetitive transcranial magnetic stimulation of the prefrontal cortex in depression. Exp Neurol. 2009 Sep; 219(1):2-13.
    View in: PubMed
    Score: 0.036
  23. Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS). Brain Stimul. 2009 Apr; 2(2):88-92.
    View in: PubMed
    Score: 0.036
  24. Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. Neuropsychopharmacology. 2009 Jan; 34(2):522-34.
    View in: PubMed
    Score: 0.034
  25. Prefrontal EEG asymmetry as a potential biomarker of antidepressant treatment response with transcranial magnetic stimulation (TMS): a case series. Clin EEG Neurosci. 2008 Jul; 39(3):125-30.
    View in: PubMed
    Score: 0.034
  26. Significant analgesic effects of one session of postoperative left prefrontal cortex repetitive transcranial magnetic stimulation: a replication study. Brain Stimul. 2008 Apr; 1(2):122-7.
    View in: PubMed
    Score: 0.033
  27. A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders. Brain Stimul. 2008 Apr; 1(2):112-21.
    View in: PubMed
    Score: 0.033
  28. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial. J Clin Psychiatry. 2008 Mar; 69(3):441-51.
    View in: PubMed
    Score: 0.033
  29. A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia. Schizophr Res. 2007 Jul; 93(1-3):42-50.
    View in: PubMed
    Score: 0.031
  30. Transcranial magnetic stimulation: a stimulating new method for treating depression, but saddled with the same old problems. Int J Neuropsychopharmacol. 2006 Dec; 9(6):637-40.
    View in: PubMed
    Score: 0.030
  31. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry. 2005 Sep 01; 58(5):364-73.
    View in: PubMed
    Score: 0.028
  32. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry. 2005 Sep; 66(9):1097-104.
    View in: PubMed
    Score: 0.028
  33. A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cogn Behav Neurol. 2004 Jun; 17(2):109-17.
    View in: PubMed
    Score: 0.025
  34. Mechanisms and the current state of transcranial magnetic stimulation. CNS Spectr. 2003 Jul; 8(7):496-514.
    View in: PubMed
    Score: 0.024
  35. Prefrontal cortex transcranial magnetic stimulation does not change local diffusion: a magnetic resonance imaging study in patients with depression. Cogn Behav Neurol. 2003 Jun; 16(2):128-35.
    View in: PubMed
    Score: 0.024
  36. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord. 2003 Feb; 5(1):40-7.
    View in: PubMed
    Score: 0.023
  37. Mechanisms and state of the art of transcranial magnetic stimulation. J ECT. 2002 Dec; 18(4):170-81.
    View in: PubMed
    Score: 0.023
  38. A transdiagnostic review of safety, efficacy, and parameter space in accelerated transcranial magnetic stimulation. J Psychiatr Res. 2022 08; 152:384-396.
    View in: PubMed
    Score: 0.022
  39. Daily prefrontal closed-loop repetitive transcranial magnetic stimulation (rTMS) produces progressive EEG quasi-alpha phase entrainment in depressed adults. Brain Stimul. 2022 Mar-Apr; 15(2):458-471.
    View in: PubMed
    Score: 0.022
  40. The Effects of Focal Electrically Administered Seizure Therapy Compared With Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy on Suicidal Ideation: A 2-Site Clinical Trial. J ECT. 2021 12 01; 37(4):256-262.
    View in: PubMed
    Score: 0.021
  41. Prefrontal transcranial magnetic stimulation for depression in US military veterans - A naturalistic cohort study in the veterans health administration. J Affect Disord. 2022 01 15; 297:671-678.
    View in: PubMed
    Score: 0.021
  42. The evidence is in: Repetitive transcranial magnetic stimulation is an effective, safe and well-tolerated treatment for patients with major depressive disorder. Aust N Z J Psychiatry. 2022 07; 56(7):745-751.
    View in: PubMed
    Score: 0.021
  43. Deep Transcranial Magnetic Stimulation Combined With Brief Exposure for Posttraumatic Stress Disorder: A Prospective Multisite Randomized Trial. Biol Psychiatry. 2021 11 15; 90(10):721-728.
    View in: PubMed
    Score: 0.021
  44. A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT). Brain Stimul. 2020 Sep - Oct; 13(5):1416-1425.
    View in: PubMed
    Score: 0.020
  45. Distinct Symptom-Specific Treatment Targets for Circuit-Based Neuromodulation. Am J Psychiatry. 2020 05 01; 177(5):435-446.
    View in: PubMed
    Score: 0.019
  46. Transcranial magnetic stimulation: applications in neuropsychiatry. Arch Gen Psychiatry. 1999 Apr; 56(4):300-11.
    View in: PubMed
    Score: 0.018
  47. The assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form (ATHF-SF). J Psychiatr Res. 2019 06; 113:125-136.
    View in: PubMed
    Score: 0.018
  48. Simple Electroencephalographic Treatment-Emergent Marker Can Predict Repetitive Transcranial Magnetic Stimulation Antidepressant Response-A Feasibility Study. J ECT. 2018 Dec; 34(4):274-282.
    View in: PubMed
    Score: 0.017
  49. Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans: A Randomized Clinical Trial. JAMA Psychiatry. 2018 09 01; 75(9):884-893.
    View in: PubMed
    Score: 0.017
  50. BDNF genotype and tDCS interaction in aphasia treatment. Brain Stimul. 2018 Nov - Dec; 11(6):1276-1281.
    View in: PubMed
    Score: 0.017
  51. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebo-controlled crossover trial. Am J Psychiatry. 1997 Dec; 154(12):1752-6.
    View in: PubMed
    Score: 0.016
  52. Combining therapeutic approaches: rTMS and aerobic exercise in post-stroke depression: a case series. Top Stroke Rehabil. 2018 01; 25(1):61-67.
    View in: PubMed
    Score: 0.016
  53. Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55.
    View in: PubMed
    Score: 0.016
  54. Expanded Safety and Efficacy Data for a New Method of Performing Electroconvulsive Therapy: Focal Electrically Administered Seizure Therapy. J ECT. 2016 Sep; 32(3):197-203.
    View in: PubMed
    Score: 0.015
  55. Five-Year Follow-Up of Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression. Brain Stimul. 2016 Nov - Dec; 9(6):897-904.
    View in: PubMed
    Score: 0.015
  56. Motor/Prefrontal Transcranial Direct Current Stimulation (tDCS) Following Lumbar Surgery Reduces Postoperative Analgesia Use. Spine (Phila Pa 1976). 2016 May; 41(10):835-9.
    View in: PubMed
    Score: 0.015
  57. The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder. Brain Stimul. 2016 May-Jun; 9(3):336-346.
    View in: PubMed
    Score: 0.014
  58. Randomized Placebo-Controlled Trial of Methylphenidate or Galantamine for Persistent Emotional and Cognitive Symptoms Associated with PTSD and/or Traumatic Brain Injury. Neuropsychopharmacology. 2016 Apr; 41(5):1191-8.
    View in: PubMed
    Score: 0.014
  59. Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study. J Psychiatr Res. 2014 Dec; 59:101-7.
    View in: PubMed
    Score: 0.013
  60. Executive control circuitry differentiates degree of success in weight loss following gastric-bypass surgery. Obesity (Silver Spring). 2013 Nov; 21(11):2189-2196.
    View in: PubMed
    Score: 0.012
  61. A feasibility study of a new method for electrically producing seizures in man: focal electrically administered seizure therapy [FEAST]. Brain Stimul. 2013 May; 6(3):403-8.
    View in: PubMed
    Score: 0.012
  62. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression. Depress Anxiety. 2012 Oct; 29(10):883-90.
    View in: PubMed
    Score: 0.011
  63. Prefrontal rTMS for treating depression: location and intensity results from the OPT-TMS multi-site clinical trial. Brain Stimul. 2013 Mar; 6(2):108-17.
    View in: PubMed
    Score: 0.011
  64. Bilateral epidural prefrontal cortical stimulation for treatment-resistant depression. Biol Psychiatry. 2010 Jan 15; 67(2):101-9.
    View in: PubMed
    Score: 0.009
  65. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry. 2007 Dec 01; 62(11):1208-16.
    View in: PubMed
    Score: 0.008
  66. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial. Biol Psychiatry. 2005 Sep 01; 58(5):347-54.
    View in: PubMed
    Score: 0.007
  67. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 2005 Sep 01; 58(5):355-63.
    View in: PubMed
    Score: 0.007
  68. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett. 2005 Mar 16; 376(3):177-81.
    View in: PubMed
    Score: 0.007
  69. Managing the risks of repetitive transcranial stimulation. CNS Spectr. 2003 Jul; 8(7):489.
    View in: PubMed
    Score: 0.006
  70. Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study. Neurocase. 2003 Jun; 9(3):274-82.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.